Watch Ticker

ANI Pharmaceuticals, Inc.

Go to ANI Pharmaceuticals, Inc. Website

$64.30

0.37 (0.58%)

Live

Previous Close

$65.43

Day Range

$63.67 - $65.57

Previous Day Range

$62.675 - $64.38

Market Cap

$1.4 billion USD

Day Vol.

204814

Previous Day Vol.

318815

Currency

USD

Primary Exchange

Nasdaq

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

ANI Pharmaceuticals reported record quarterly net revenues of $197.1 million, a 43.4% year-over-year growth. The company's Rare Disease business generated $69.0 million in quarterly net revenues and presented preclinical data on the use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis mouse model.

Related tickers: ANIP.

Read Full Article

Vandana Singh - ANI Pharmaceuticals Expects Strong Start To 2025, On Back Of Cortrophin Gel And Generics, Lifts Annual Forecast

ANI Pharmaceuticals reported strong Q4 results, with adjusted EPS and sales beating estimates. The company raised its 2025 guidance for revenue and adjusted EPS, driven by growth in its Cortrophin Gel, generics, and branded products.

Related tickers: ANIP.

Read Full Article

Trending Tickers

Please sign in to view